Evidence map›Paper›PMID 40668807›Full record

ArticlePloS one2025

The relationship between maternal COVID-19 with fetal and neonatal complications and intrauterine vertical transmission: A cohort study on pregnant women.

Zahra Shafizadeh, Zahra Akbarian-Rad, Fatemeh Nasiri-Amiri, Mostafa Javanian, Hamid Reza Nouri, Mehdi Rajabnia, Zahra Geraili, Shanaz Barat, Jamileh Aqatabar Roudbari

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Zahra ShafizadehStudent Research Committee, Babol University of Medical Sciences, Babol, Iran.
Zahra Akbarian-RadAmirkola Children's Non-Communicable Diseases Research Center, Babol University of Medical Sciences, Babol, Iran.
Fatemeh Nasiri-AmiriInfertility and Health Reproductive Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.ORCID https://orcid.org/0000-0001-6794-7627
Mostafa JavanianInfectious Diseases and Tropical Medicine Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.
Hamid Reza NouriCellular and Molecular Biology Research Center, Health Research Institute, University of Medical Sciences, Babol, Iran.
Mehdi RajabniaInfectious Diseases and Tropical Medicine Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.
Zahra GerailiSocial Determinants of Health Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.
Shanaz BaratInfertility and Health Reproductive Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.
Jamileh Aqatabar RoudbariOffice of the vice-chancellor of the university, Department of Midwifery, Babol University of Medical Sciences, Babol, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe clinical features, maternal and fetal complications, and the potential for vertical transmission of SARS-CoV-2 infection in pregnant women are still unknown. This cohort study aimed to determine the relation of coronavirus infection to the incidence of fetal and neonatal complications by comparing outcomes in pregnant women with COVID-19 to those in non-infected pregnant women.

methodThis prospective cohort study was conducted on all pregnant women who gave birth between September 2020 to September 2021 at Rouhani Hospital, Iran. The case group included pregnant women infected with SARS-CoV-2, confirmed by clinical signs, symptoms and positive result of Real-time polymerase chain reaction (real-time PCR), who were followed up until 72 hours after birth. All fetal and neonatal complications, such as premature birth, oligohydramnios, fetal growth restriction, perinatal death and vertical transmission were recorded. Risk ratios for adverse pregnancy outcomes were analyzed by a modified Poisson regression model adjusted for relevant variables.

resultsThe final sample included 234 pregnant women (100 COVID-19 infected and 134 non-infected). The mean age was 29.42 ± 6.16 years (p = 0.12), and the mean BMI (body mass index) was 26.51 ± 4.16) Kg/m2 (p = 0.30). Cesarean delivery was more common among women with COVID -19 [adjusted risk ratio (aRR): 1.12, 95% confidence interval (CI): 1.09-1.25, p = 0.03]. A significant increase was observed in neonatal intensive care unit (NICU) admission in SARS-CoV-2 infected pregnant women compared to non-infected pregnant women [adjusted risk ratio (aRR):2.46, 95% confidence interval (CI): 1.06-5.42, P = 0.034]. Neonate born to women with COVID-19 had significantly higher rate of preterm birth (22% versus 11.2%) and low 5 minutes APGAR score (2% versus 0%) significantly (P < 0.05). Nearly all newborns tested negative for SARS-CoV-2 infection after birth (97.94%). Of 76 cord blood samples tested, 16 (21.05%) and 4 (5.26%) cases of infants born to mothers infected with COVID-19 had positive IgG and IgM antibodies, respectively.

conclusionsNeonates born to mothers with COVID-19 faced a significantly higher risk of cesarean delivery and NICU admission, but no significant differences in other pregnancy complications were observed between COVID-19 and non-infected groups, highlighting the complex effects of the virus on pregnancy outcomes.

Indexed as

COVID-19Infectious Disease Transmission, VerticalPregnancy Complications, InfectiousAdultCohort StudiesFemaleHumansInfant, NewbornIranPregnancyPregnancy OutcomePremature BirthProspective StudiesSARS-CoV-2

Identifiers

PMID40668807
PMCPMC12266458

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.